TY - JOUR
T1 - Continuous Flow Synthesis of Copper Oxide Nanoparticles Enabling Rapid Screening of Synthesis-Structure-Property Relationships
AU - Jellicoe, Matt
AU - Yang, Yibo
AU - Stokes, William
AU - Simmons, Matthew
AU - Yang, Lina
AU - Foster, Stephanie
AU - Aslam, Zabeada
AU - Cohen, Jennifer
AU - Rashid, Ashi
AU - Nelson, Andrew L.
AU - Kapur, Nikil
AU - Drummond-Brydson, Rik
AU - Chamberlain, Thomas W.
PY - 2025/2/12
Y1 - 2025/2/12
N2 - An adjustable and scalable method for the continuous flow synthesis of cupric oxide nanoparticles (CuO NPs), targetted the reduction of their activity to synthetic biomembranes to inform the fabrication of nanoparticles (NPs) with reduced toxicity for commercial applications. By manipulating key factors; temperature, residence time, and the ratio of precursor to reductant, precise control over the morphology of CuO NPs is achieved with X-ray diffraction (XRD) and transmission electron microscopy (TEM) confirming the formation of needle-shaped CuO NPs. One-variable-at-a-time studies reveal a relationship between the synthesis conditions and the characteristics of the resultant NPs, with CuO NPs varying controllably between 10–50 nanometres in length and 4–10 nanometres in width. Subsequently, Design of Experiment (DoE) exploration of the biomembrane activity of the CuO NPs intriguingly revealed only minimal effects on their membrane-disruptive properties in the chemical space defined by the synthesis conditions explored. This study marks a significant milestone, as it introduces a facile, easy to scale, continuous flow synthesis of CuO NPs, with control over the length and width of the needle NPs and reveals that, regardless of the exact shape, the NPs have minimal impact on biomembranes, prompting more detailed exploration in the future for use in biomedical applications.
AB - An adjustable and scalable method for the continuous flow synthesis of cupric oxide nanoparticles (CuO NPs), targetted the reduction of their activity to synthetic biomembranes to inform the fabrication of nanoparticles (NPs) with reduced toxicity for commercial applications. By manipulating key factors; temperature, residence time, and the ratio of precursor to reductant, precise control over the morphology of CuO NPs is achieved with X-ray diffraction (XRD) and transmission electron microscopy (TEM) confirming the formation of needle-shaped CuO NPs. One-variable-at-a-time studies reveal a relationship between the synthesis conditions and the characteristics of the resultant NPs, with CuO NPs varying controllably between 10–50 nanometres in length and 4–10 nanometres in width. Subsequently, Design of Experiment (DoE) exploration of the biomembrane activity of the CuO NPs intriguingly revealed only minimal effects on their membrane-disruptive properties in the chemical space defined by the synthesis conditions explored. This study marks a significant milestone, as it introduces a facile, easy to scale, continuous flow synthesis of CuO NPs, with control over the length and width of the needle NPs and reveals that, regardless of the exact shape, the NPs have minimal impact on biomembranes, prompting more detailed exploration in the future for use in biomedical applications.
KW - continuous flow
KW - nanoparticles
KW - optimization
KW - toxicity
UR - http://www.scopus.com/inward/record.url?scp=85214439756&partnerID=8YFLogxK
U2 - 10.1002/smll.202403529
DO - 10.1002/smll.202403529
M3 - Article
AN - SCOPUS:85214439756
SN - 1613-6810
VL - 21
JO - Small
JF - Small
IS - 6
M1 - 2403529
ER -